Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Non-Prescription Drug Modernization Act of 2007
Client: JOHNSON & JOHNSON · Firm: MARY PENDERGAST
HR 4083, S 2311, non-prescription Drug Act of 2007; determining how to update and improve FDA regulation of OTC drugs
Non-Prescription Drug Modernization Act of 2007
Client: JOHNSON & JOHNSON · Firm: MARY PENDERGAST
HR 4083, S 2311, non-prescription Drug Act of 2007; determining how to update and improve FDA regulation of OTC drugs
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
JOHNSON & JOHNSON via MARY PENDERGAST
2008 · third_quarter · 3A
HR 4083, S 2311, non-prescription Drug Act of 2007; determining how to update and improve FDA regulation of OTC drugs
JOHNSON & JOHNSON via MARY PENDERGAST
2008 · first_quarter · RR
Source: Senate LDA
legislation pertaining to the Food and Drug Administration's activities
legislation pertaining to the Food and Drug Administration's activities
legislation pertaining to the Food and Drug Administration's activities